SCHEMBL6406364

SCHEMBL6406364

COc1ccc2c(c1)C(=O)[N]C(=O)N2C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.42
▸ KDM4E B2RXH2 4/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ SCN2A Q99250 1/20 0.39
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA4 P22748 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ HTT P42858 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ IDO1 P14902 2/20 0.37
▸ KYAT1 Q16773 1/20 0.36
▸ KYAT3 Q6YP21 1/20 0.36
▸ AADAT Q8N5Z0 1/20 0.36
▸ NOTUM Q6P988 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6401710 0.80 P2RX4 (0.40) KDM4EALDH1A1MAPTCA1CA2
SCHEMBL6401445 0.73 ALPL (0.32) —
SCHEMBL9834316 0.69 HSD17B10 (0.53) HSD17B10KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3377831 0.68 CA1 (0.52) KDM4ECYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL11536134 0.66 HSD17B10 (0.44) HSD17B10KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL11111881 0.62 LMNA (0.66) —
SCHEMBL5712056 0.62 NOTUM (0.57) HSD17B10KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL211764 0.61 HSD17B10 (0.45) HSD17B10KDM4EALDH1A1MAPTCA1
SCHEMBL3233069 0.61 KDM4E (0.43) HSD17B10KDM4EALDH1A1MAPTCA1
SCHEMBL3226307 0.61 KDM4E (0.43) KDM4EMAPTCA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 — — US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 — — EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 — — US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 HSD17B10 1103/4885KDM4E 1617/4885CYP1A2 490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback